Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Alcohol swabs, clean gauze or cotton balls , and optionally a band-aid
Nerve-related back pain Radicular pain, sciatica, and other nerve-mediated back pain conditions present unique challenges
Most common adverse events at all doses: Nausea (3355%, dose-related) Vomiting (1335%) Decreased appetite (1528%) Constipation or diarrhea (1020%) Injection-site reaction (510%) Dose-related dysesthesia signal: The TRIUMPH-4 trial identified a dose-related dysesthesia (nerve-tingling, paresthesia) signal: This is the most-flagged trial-level safety signal for retatrutide and the reason community doses cluster at 2-4 mg/week well below where the dysesthesia signal becomes prominent
VASCULAR GROWTH & BLOOD VESSEL STIMULATION
NDC: 70069-0005-10
Because of this interaction, the compound has become a subject of interest in research focused on metabolic biology and enzymatic regulation
